Pro-Dex Profit Margin 2006-2019 | PDEX

Current and historical gross margin, operating margin and net profit margin for Pro-Dex (PDEX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Pro-Dex net profit margin as of March 31, 2019 is 12.98%.
Pro-Dex Annual Profit Margins
Pro-Dex Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.059B $0.022B
Pro-Dex Inc., with operations in Santa Ana, California, Beaverton, Oregon and Carson City Nevada, specializes in bringing speed to market in the development and manufacture of technology-based solutions that incorporate embedded motion control, miniature rotary drive systems and fractional horsepower DC motors, serving the medical, dental, semi-conductor, scientific research and aerospace markets. Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, scientific research facilities, commercial and military aircraft, and high tech manufacturing operations globally.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $67.805B 22.59
McKesson (MCK) United States $26.644B 10.52
Align Technology (ALGN) United States $22.487B 60.71
AmerisourceBergen (ABC) United States $18.706B 13.28
Laboratory Of America Holdings (LH) United States $17.242B 16.12
Cooper (COO) United States $16.241B 28.07
Cardinal Health (CAH) United States $13.946B 9.03
Straumann Holding AG (SAUHF) Switzerland $13.423B 0.00
DENTSPLY SIRONA (XRAY) United States $13.213B 27.55
Henry Schein (HSIC) United States $10.425B 17.53
West Pharmaceutical Services (WST) United States $9.055B 42.06
Merit Medical Systems (MMSI) United States $3.106B 32.27
CONMED (CNMD) United States $2.409B 38.44
Patterson (PDCO) United States $2.031B 15.22
Atrion (ATRI) United States $1.461B 41.73
STAAR Surgical (STAA) United States $1.413B 96.27
Antares Pharma (ATRS) United States $0.483B 0.00
Lifevantage (LFVN) United States $0.166B 21.92
Invacare (IVC) United States $0.160B 0.00
Endologix (ELGX) United States $0.112B 0.00